Single nucleotide polymorphisms (SNPs) in MYH9 and APOL1 on chromosome 22 (c22) are powerfully associated with non-diabetic end-stage renal disease (ESRD) in African Americans (AAs). Many AAs diagnosed with type 2 diabetic nephropathy (T2DN) have non-diabetic kidney disease, potentially masking detection of DN genes. Therefore, genome-wide association analyses were performed using the Affymetrix SNP Array 6.0 in 966 AA with T2DN and 1,032 non-diabetic, non-nephropathy (NDNN) controls, with and without adjustment for c22 nephropathy risk variants. No associations were seen between FRMD3 SNPs and T2DN before adjusting for c22 variants. However, logistic regression analysis revealed seven FRMD3 SNPs significantly interacting with MYH9—a finding replicated in 640 additional AA T2DN cases and 683 NDNN controls. Contrasting all 1,592 T2DN cases with all 1,671 NDNN controls, FRMD3 SNPs appeared to interact with the MYH9 E1 haplotype (e.g., rs942280 interaction p-value = 9.3E−7 additive; odds ratio [OR] 0.67). FRMD3 alleles were associated with increased risk of T2DN only in subjects lacking two MYH9 E1 risk haplotypes (rs942280 OR = 1.28), not in MYH9 E1 risk allele homozygotes (rs942280 OR = 0.80; homogeneity p-value = 4.3E−4). Effects were weaker stratifying on APOL1. FRMD3 SNPS were associated with T2DN, not type 2 diabetes per se, comparing AAs with T2DN to those with diabetes lacking nephropathy. T2DN-associated FRMD3 SNPs were detectable in AAs only after accounting for MYH9, with differential effects for APOL1. These analyses reveal a role for FRMD3 in AA T2DN susceptibility and accounting for c22 nephropathy risk variants can assist in detecting DN susceptibility genes.
Vyšlo v časopise: Differential Effects of and Risk Variants on Association with Diabetic ESRD in African Americans. PLoS Genet 7(6): e32767. doi:10.1371/journal.pgen.1002150 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002150
1. KoppJBSmithMWNelsonGWJohnsonRCFreedmanBI 2008 MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40 1175 1184
2. KaoWHKlagMJMeoniLAReichDBerthier-SchaadY 2008 MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40 1185 1192
3. FreedmanBIHicksPJBostromMACunninghamMELiuY 2009 Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75 736 745
4. FreedmanBIHicksPJBostromMAComeauMEDiversJ 2009 Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 11 3366 3371
5. FreedmanBIKoppJBWinklerCANelsonGWRaoDC 2009 Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol 29 626 632
6. Reeves-DanielAMIskandarSSBowdenDWBostromMAHicksPJ 2010 Is Collapsing C1q Nephropathy Another MYH9-Associated Kidney Disease? A Case Report. American Journal of Kidney Diseases 55 e21 e24
7. PattaroCAulchenkoYSIsaacsAVitartVHaywardC 2009 Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int 76 297 306
8. GenoveseGFriedmanDJRossMDLecordierLUzureauP 2010 Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329 841 845
9. TzurSRossetSShemerRYudkovskyGSeligS 2010 Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128 345 350
10. FreedmanBIKoppJBLangefeldCDGenoveseGFriedmanDJ 2010 The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans. Journal of the American Society of Nephrology 21 1422 1426
11. NelsonGWFreedmanBIBowdenDWLangefeldCDAnP 2010 Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet 19 1805 1815
12. GopalakrishnanIIskandarSSDaeihaghPDiversJLangefeldCD 2011 Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol 42 291 294
13. DiversJFreedmanBI 2010 Susceptibility genes in common complex kidney disease. Curr Opin Nephrol Hypertens 19 79 84
14. NunezMSaranAMFreedmanBI 2010 Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene. Adv Chronic Kidney Dis 17 44 51
15. McDonoughCWPalmerNDHicksPJRohBHAnSS 2011 A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 79 5 563 572
16. KottgenAGlazerNLDehghanAHwangSJKatzR 2009 Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet
17. PezzolesiMGPoznikGDMychaleckyjJCPatersonADBaratiMT 2009 Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58 6 1403 1410
18. MureaMFreedmanBI 2010 Essential hypertension and risk of nephropathy: a reappraisal. Curr Opin Nephrol Hypertens
19. KottgenAPattaroCBogerCAFuchsbergerCOldenM 2010 New loci associated with kidney function and chronic kidney disease. Nat Genet 11 (In Press)
20. MaedaSArakiSIBabazonoTToyodaMUmezonoT 2010 Replication study for the association between 4 loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes
21. RamezMBlot-ChabaudMCiuzeaudFChananSPattersonM 2003 Distinct distribution of specific members of protein 4.1 gene family in the mouse nephron. Kidney Int 63 1321 1337
22. FrameMCPatelHSerrelsBLiethaDEckMJ 2010 The FERM domain: organizing the structure and function of FAK. Nat Rev Mol Cell Biol 11 802 814
23. NiXJiCCaoGChengHGuoL 2003 Molecular cloning and characterization of the protein 4.10 gene, a novel member of the protein 4.1 family with focal expression in ovary. J Hum Genet 48 101 106
24. HooverKBBryantPJ 2000 The genetics of the protein 4.1 family: organizers of the membrane and cytoskeleton. Curr Opin Cell Biol 12 229 234
25. ChishtiAHKimACMarfatiaSMLutchmanMHanspaiM 1998 The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23 281 282
26. BainesAJ 2006 A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function. BMC Genomics 20 85
27. TangHPengJWangPRischNJ 2005 Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol 28 289 301
28. PiegorschWWWeinbergCRTaylorJA 1994 Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 13 153 162
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
